Dark

SGMO
Sangamo Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Aug 29, 2025 3:59:30 PM EDT

0.5201USD-3.916%(-0.0212)3,578,369

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Aug 29, 2025 9:27:30 AM EDT

0.5439USD+0.480%(+0.0026)30,858

After-hours

Aug 29, 2025 4:55:30 PM EDT

0.5251USD+0.961%(+0.0050)47,698

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

156.92M

CEO

Alexander Macrae

Headquarters

Brisbane, California, USA

Industry

Biotechnology

Next Earnings

Oct 30, 2025 (61d)

AMGN BMRN SHPG GILD BIIB ALNY PDLI JNJ MRK DWDP XLV

SGMO Stats

Avg. Vol. 10 Day

4,280,650

Avg. Vol. 30 Day

6,663,368

Employees

209

Market Cap

156,919,103

Shares Out.

301,709,485

On/Off Exchange

27%/73%

6 Month Beta

0.87

1 Year Beta

1.63

2 Year Beta

1.51

3 Year Beta

1.53

52 Week Low

0.41

52 Week High

3.18

SMA50

0.53

SMA200

1.00

1 Week

-11.29%

1 Month

-4.57%

3 Month

+11.85%

6 Month

-43.50%

1 Year

-38.67%

2 Year

-45.14%

5 Year

-95.29%

Profile

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.

SGMO Stock Summary

Sangamo Therapeutics, Inc. Common Stock (NASDAQ:SGMO) stock price today is $0.5201, and today's volume is 3,578,369. SGMO is down -3.916% today. The 30 day average volume is 6,663,368. SGMO market cap is 156.92M with 301,709,485 shares outstanding.